We find a strong synergism between tumor necrosis factor (TNF) and bacteria or their products. Endotoxin-"free" recombinant TNF, even at very high doses (160 ,ug), did not alone cause hemorrhagic necrosis (RN) in the skin of normal mice. Similarly, TNF alone had a low systemic toxicity in tumor-and pathogen-free mice. However, TNF given intravenously with nanogram quantities of the endotoxin lipopolysaccharide caused lethal shock. Furthermore, subcutaneous injection of lipopolysaccharide made skin susceptible to subsequent induction of HN by TNF injected in the same site 24 hr later. Mycoplasma-infected cells or corynebacteria also synergized with TNF to cause HN or lethal shock. In addition, we find that lymphotoxin, a cytokine functionally and genetically related to TNF, also synergized with the bacteria to cause HN, whereas interleukin la or interferon y did not. Together, the results indicate that a synergy between TNF and bacteria or their products causes HN and lethal shock in normal mice.
Certain bacterial products, such as the endotoxin lipopolysaccharide (LPS), induce the release of a factor into serum that causes hemorrhagic necrosis (HN) of tumors and is called tumor necrosis factor (TNF; ref. 1) . TNF has been cloned and the recombinant material, like the native product, causes HN of tumors (2) . It is of major concern that, in addition, the recombinant TNF has been found to induce many of the deleterious effects of endotoxin, such as lethal shock and disseminated HN (3). It is not clear why this systemic toxicity of TNF in vivo was only found after recombinant preparations of TNF became available and why it had not been observed in previous studies using nonrecombinant sources of TNF (for review, see ref. 4) . The higher systemic toxicity of recombinant TNF could be due to the use of higher doses, to structural differences between the recombinant and nonrecombinant TNF molecules, or to impurities in the recombinant preparations (4) .
Interestingly, we find that recombinant TNF, which is virtually endotoxin-free, has a low toxicity in the absence of added endotoxin or other microbial agents so long as tumorfree and pathogen-free animals are tested. However, we observe a very strong synergism between TNF and LPS endotoxin or between TNF and other bacteria in causing lethal shock or HN in normal tissues.
MATERIALS AND METHODS
Mice. Six-to 10-week-old, pathogen-free, female mice of the C3H/HeN, C3H/HeJ, athymic NCR nu/nu, and BALB/cAn strains were purchased from a germ-freederived, defined-flora colony at the Frederick Cancer Research Institute (Frederick, MD) and maintained in pathogen-free conditions in laminar flow hoods.
Cytokines and Bacteria. Recombinant human TNF (lot 3056-55) and recombinant human lymphotoxin (LT; lot 4260-1) had specific activities of 5 .01 x 107 units (U)/mg and 1.02 x 108 U/mg, respectively, based on cytotoxicity of actinomycin D-treated L929 mouse fibroblast cells (5) . Recombinant murine interferon y (IFN-,y; lot 4407-47) had a specific activity of 1.97 x 107 U/mg. TNF, LT, and IFN-y were obtained from Genentech. Recombinant human interleukin la (IL-la; lot SM63) had a specific activity of 5 x 109 U/mg and was obtained from Hoffmann-La Roche. Endotoxin levels of cytokines, expressed as endotoxin units (EU), were TNF c 0.125 EU/ml, IL-la < 15 EU/ml, IFN-y < 2 EU/ml, and LT c 0.062 EU/ml, as measured in the Limulus amoebocyte lysate assay given that 1 EU is equal to 0.1 ng/ml of USP standard Escherichia coli endotoxin (lot EC5). The LPS endotoxin of E. coli 0111:B4 (lot 743397, Difco) was diluted in nonpyrogenic saline (Invenex Labs, Melrose Park, IL) to 10 mg/ml and sterilized by 0.22-npm filtration before use. Heat-killed Corynebacterium parvum (lot 608122, Behring Diagnostics, San Diego, CA) was diluted in nonpyrogenic saline to 10 mg/ml before use. Mycoplasma orale was passaged by intracellular growth in vitro and expanded with the cells for the generation of lysate as described below.
Cell Lines. The UV-induced fibrosarcomas 1591-RE and 1316-RE, normal heart-lung fibroblast strains, and 10T½2 cells (an untransformed fibroblast line) were obtained and passaged as described (6) .
Assay for HN and Lethal Shock. The lower backs of mice were shaven and then depilated with a chemical depilator (Nair, Carter-Wallace, New York). Test material was injected subcutaneously (s.c.) with or without TNF. Removing the hair before the start of the experiment did not influence the results and for convenience, therefore, we usually depilated the skin before the start of the experiment. The degree of HN was scored 24 hr later and in some cases skin sections were examined microscopically. Cell lysates used for induction of necrosis were generated by three cycles of freezethawing followed by a 30-min sonication. In some experiments, mice were primed for HN with LPS (100 ,tg) injected s.c. 24 hr before cytokine injection. To study the systemic toxicity of mixtures of TNF and LPS or TNF and C. parvum, the materials were coinjected i.v. by way of the retroorbital plexus.
RESULTS
Synergism Between LPS and TNF in Causing Lethal Shock.
When normal pathogen-free C3H/HeN mice were injected i.v. with human TNF no lethality was observed except at the Abbreviations: EU, endotoxin unit(s); HN, hemorrhagic necrosis; IFN-y, interferon y; IL-la, interleukin la; LPS, lipopolysaccharide;
LT, lymphotoxin; PML, polymorphonuclear leukocyte(s); TNF, tumor necrosis factor. *To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. injection (Table 1 , second column); death occurred in <24 hr with symptoms similar to those observed after injection of high doses of LPS (piloerection, lethargy, diarrhea, fluid exudation around eyes). i.v. injections of 100 ttg of LPS alone per mouse caused <10% lethality (Table 1 ). In contrast, we observed in repeated experiments that combined doses (lower by a factor of 8 than individual doses of TNF or LPS that caused only 10% lethality) killed 100% of the mice. Furthermore, doses of LPS as low as 23 ng caused 50% lethality when applied with a nonlethal dose of TNF. An isobologram ( Fig. 1 Upper) dramatizes that the combined doses of TNF and endotoxin were markedly synergistic and not additive. Similar synergism was also observed when another strain of LPS-sensitive pathogen-free mice (BALB/ cAn) was treated with combinations of TNF and LPS. The development of HN was independent of a functional T-cell immunity since athymic nude mice developed HN after sequential injections of LPS and TNF ( Fig. 2A) . Furthermore, y-irradiation (650 rads), which causes leukopenia, prevented the HN produced by sequential LPS and TNF injections. As expected, C3H/HeJ mice, known to be genetically resistant to the endotoxin effects (8) (Fig. 2B) caused a similar HN in athymic and normal mice, but ry-irradiated mice did not respond, indicating that the induction of HN with mycoplasma-positive cell lysates and TNF was (like the HN induced by LPS and TNF) T-cell independent and radiosensitive. As expected, the LPS-sensitive and LPS-insensitive C3H strains both responded equally well to mycoplasma and TNF as did BALB/cAn mice. An unrelated (Gram-positive) organism, C. parvum, coinjected s.c. as a bacterial suspension mixed with TNF, also caused massive HN (Fig. 2C) at the skin site of injection without causing deaths in three strains of mice, including nude mice (Table 3 ). Boiling C. parvum or the mycoplasma-positive cell lysates for 1 hr did not destroy the activity of the materials to synergize with TNF. C. parvum and TNF failed to cause deaths when injected together s.c. However, C. parvum with TNF injected together i.v. synergized in causing lethal shock, though the degree of synergism in causing lethality was less than that caused by LPS and TNF ( Fig. 1 Upper and Lower).
IL-1a or IFN-y Fails to Synergize with Bacteria or TNF in the Induction of HN. IL-la has a number of functional similarities with TNF (for review, see ref. 11) and a nonrecombinant material containing IL-1 has been implicated in the Shwartzman reaction (12) . However, Table 4 shows that the recombinant cytokine, IL-la, failed to substitute for TNF in synergizing with C. parvum to induce HN. Similarly, IFN-y also failed to synergize with C. parvum to induce HN. In contrast, LT (13, 14) , which is encoded by a closely linked gene (15) with significant sequence homology to TNF, can substitute for TNF in causing HN with C. parvum, although in repeated experiments LT was less effective. IFN-y is known to synergize with TNF in killing tumor cells in vitro (16) (17) (18) . However, neither IFN-y nor IL-la could replace the bacterial component and synergize with TNF to induce HN.
DISCUSSION
Determining the reasons for the toxicity of recombinant TNF was important not only because toxicity would limit the therapeutic usefulness of recombinant preparations but also because such studies may help us to understand the biologic effects of TNF. Since the endotoxin LPS is a potent stimulator for macrophages to produce TNF (6) and since antibodies to recombinant TNF can prevent the development of endotoxin shock (19) , it is conceivable that TNF, as a single protein mediator, causes the deleterious effects without further participation of endotoxin. Although such a possibility appears plausible, especially since TNF alone can be directly cytotoxic to malignant cells (1) or inhibit the function of certain enzymes in vitro (20) , such a notion is not supported by the results of the experiments presented here.
In this paper, we show that certain bacteria or bacterial substances can have a high degree of synergy with TNF to cause HN and/or lethal shock. At present, we cannot determine whether the marginal systemic toxicity of TNF observed at the highest doses was due to TNF alone, whether it was caused by contamination of the recombinant TNF preparation with very small amounts of endotoxin, or whether a low level of circulating endotoxin absorbed from the intestinal flora might account for the phenomenon. Similarly, there was no evidence for TNF alone being sufficient to induce HN since injecting even large doses of TNF into normal skin failed to induce any micro-or macroscopically detectable tissue injury. Thus, it appears that at least two synergistic signals (i, TNF; ii, a bacterial component) are required for lethal shock or HN to occur.
Heat killed C. parvum bacteria or mycoplasma-infected normal or malignant cell lysates, given together with TNF, had effects similar to LPS and TNF and even synergized in endotoxin-resistant mice. Together this suggests that the observed synergy may occur with infections that involve quite different bacteria or bacterial products and TNF. TNF could be given passively, be produced actively by host macrophages, or be replaced by LT, which is produced by T cells that commonly participate in the defense against infections. Possibly, different bacteria that synergize with TNF or LT share a common moiety or induce a common mediator. However, it does not appear to be IFN-y or IL-la since neither of these cytokines could substitute for the bacterial components and synergize with TNF to induce HN.
Our study suggests that the bacterial moiety and TNF are not sufficient to cause HN or lethality on their own but require a third component that comes from the host (Fig. 3) . Evidence comes from the fact that LPS and TNF induced neither lethality nor HN in mice genetically resistant to the toxic effects of endotoxin. Furthermore, leukopenia, which 4 Exp. 5 Exp. 6 Exp. has been shown to prevent the Shwartzman reaction (21-23), induced in this study by y-irradiation (650 rads), prevented the induction of HN in sensitive mice, whereas functional T cells were not required. This suggests that the host component was radiosensitive and T-cell independent. The third component might be derived from PML since these cells are implicated in the systemic and local Shwartzman reaction (22) . Possibly, the Shwartzman reaction (24) may depend on endogenously produced TNF that synergizes with sensitizing endotoxin.
The time when PML invade LPS-, mycoplasma-, or C. parvum-injected skin correlated with the time when TNF had to be injected to induce HN at the prepared skin site. The mere attraction of PML to the site of LPS injection must not be sufficient to prepare skin for the induction of HN by TNF, however, since LPS injection into the skin of LPS-resistant C3H/HeJ mice caused an equal or even more effective PML infiltrate than observed in the LPS-sensitive C3H strain (even though the LPS-resistant strain failed to respond to TNF injection into the infiltrated skin with HN). Cellular responsiveness to TNF and the bacterial agent for the induction of HN appears to be required at a step subsequent to PML infiltration. Thus, a second LPS-mediated event must be required that is defective in LPS-resistant mice.
Experimentally, TNF treatment has been shown to cause necrosis and regression of certain murine or human tumors in mice, although the sensitivity of these tumors to TNF in vivo does not always correlate with a sensitivity of the tumor cells to TNF in vitro. Since TNF alone did not cause necrosis of normal tissues, one would expect that a tumor sensitive to TNF in vivo provides a second signal analogous to the one provided by bacteria in the HN of normal skin by TNF. The circulation of this second factor may be responsible for the increased susceptibility of tumor-bearing individuals to the toxic effects of TNF (4, 25) . In cases in which tumors are resistant to TNF in vivo, this proposed second signal is not produced but could be replaced by simultaneous application of bacterial agents and TNF. On the basis of the described synergism between TNF and bacterial agents, patients bearing a tumor that has a predisposition for TNF toxicity or who are exposed advertently to bacterial agents (26) or inadvertently in the form of intercurrent infections would be more susceptible to systemic complications of TNF treatment such as lethal shock.
Although the observed synergy might appear to have adverse effects on the normal host, it is more likely that the synergy is part of an important local defense mechanism of the host against infections. For example, HN, by causing local ischemia, may prevent the rapid spread or diffusion of bacteria and of toxic products. The breakdown of this local containment reaction may be detrimental to the host because circulation of bacterial toxins inducing systemic release of cytokines may cause lethal shock.
